Pseudoneoplastic mimics of prostate and bladder carcinomas

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 3, 2010, Pages 427-443

  Hameed, Omar ^a   Humphrey, Peter A ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER DISEASE; BLADDER TUMOR; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; PLASMA CELL GRANULOMA; PROSTATE DISEASE; PROSTATE TUMOR;

DIAGNOSIS, DIFFERENTIAL; GRANULOMA, PLASMA CELL; HUMANS; MALE; PROSTATIC DISEASES; PROSTATIC NEOPLASMS; URINARY BLADDER DISEASES; URINARY BLADDER NEOPLASMS;

EID: 77749321731     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Hameed O, Humphrey PA. Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol. 2005;22(1):88-104.
2. Srigley JR. Benign mimickers of prostatic adenocarcinoma. Mod Pathol. 2004;17(3):328-348.
3. Epstein JI, Walsh PC, Sanfilippo F. Clinical and cost impact of secondopinion pathology. review of prostate biopsies prior to radical prostatectomy. Am J Surg Pathol. 1996;20(7):851-857.
4. Herawi M, Parwani AV, Irie J, Epstein JI. Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion. Am J Surg Pathol. 2005;29(7):874-880.
5. Bostwick DG, Cheng L. Overdiagnosis of prostatic adenocarcinoma. Semin Urol Oncol. 1999;17(4):199-205.
6. De Marzo AM, Platz EA, Epstein JI et al. A working group classification of focal prostate atrophy lesions. Am J Surg Pathol. 2006;30(10):1281-1291.
7. Franks LM. Atrophy and hyperplasia in the prostate proper. J Pathol Bacteriol. 1954;68(2):617-621.
8. Amin MB, Tamboli P, Varma M, Srigley JR. Postatrophic hyperplasia of the prostate gland: a detailed analysis of its morphology in needle biopsy specimens. Am J Surg Pathol. 1999;23(8):925-931.
9. Oppenheimer JR, Wills ML, Epstein JI. Partial atrophy in prostate needle cores: another diagnostic pitfall for the surgical pathologist. Am J Surg Pathol. 1998;22(4):440-445.
10. Wang W, Sun X, Epstein JI. Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study. Am J Surg Pathol. 2008;32(6): 851-857.
11. Przybycin CG, Kunju LP, Wu AJ, Shah RB. Partial atrophy in prostate needle biopsies: a detailed analysis of its morphology, immunophenotype, and cellular kinetics. Am J Surg Pathol. 2008;32(1):58-64.
12. Garcia JJ, Al-Ahmadie HA, Gopalan A et al. Do prostatic transition zone tumors have a distinct morphology? Am J Surg Pathol. 2008;32(11):1709-1714.
13. Tran TT, Sengupta E, Yang XJ. Prostatic foamy gland carcinoma with aggressive behavior: clinicopathologic, immunohistochemical, and ultrastructural analysis. Am J Surg Pathol. 2001;25(5):618-623.
14. Ruska KM, Sauvageot J, Epstein JI. Histology and cellular kinetics of prostatic atrophy. Am J Surg Pathol. 1998;22(9):1073-1077.
15. Adley BP, Yang XJ. a-Methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate. Am J Clin Pathol. 2006;126(6):849-855.
16. Cina SJ, Epstein JI. Adenocarcinoma of the prostate with atrophic features. Am J Surg Pathol. 1997;21(3):289-295.
17. Egan AJ, Lopez-Beltran A, Bostwick DG. Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process. Am J Surg Pathol. 1997;21(8):931-935.
18. Kaleem Z, Swanson PE, Vollmer RT, Humphrey PA. Prostatic adenocarcinoma with atrophic features: a study of 202 consecutive completely embedded radical prostatectomy specimens. Am J Clin Pathol. 1998;109(6):695-703.
19. Bostwick DG, Srigley J, Grignon D et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from welldifferentiated carcinoma. Hum Pathol. 1993;24(8):819-832.
20. Gaudin PB, Epstein JI. Adenosis of the prostate: histologic features in transurethral resection specimens. Am J Surg Pathol. 1994;18(9):863-870.
21. Gaudin PB, Epstein JI. Adenosis of the prostate: histologic features in needle biopsy specimens. Am J Surg Pathol. 1995;19(7):737-747.
22. Lotan TL, Epstein JI. Diffuse adenosis of the peripheral zone in prostate needle biopsy and prostatectomy specimens. Am J Surg Pathol. 2008;32(9):1360-1366.
23. Devaraj LT, Bostwick DG. Atypical basal cell hyperplasia of the prostate: immunophenotypic profile and proposed classification of basal cell proliferations. Am J Surg Pathol. 1993;17(7):645-659.
24. Yang XJ,Wu CL, Woda BA et al. Expression of a-methylacyl-coA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol. 2002;26(7):921-925.
25. Luque RJ, Lopez-Beltran A, Perez-Seoane C, Suzigan S. Sclerosing adenosis of the prostate: histologic features in needle biopsy specimens. Arch Pathol Lab Med. 2003;127(1):e14-16.
26. Grignon DJ, Ro JY, Srigley JR, Troncoso P, Raymond AK, Ayala AG. Sclerosing adenosis of the prostate gland: a lesion showing myoepithelial differentiation. Am J Surg Pathol. 1992;16(4):383-391.
27. Thorson P, Swanson PE, Vollmer RT, Humphrey PA. Basal cell hyperplasia in the peripheral zone of the prostate. Mod Pathol. 2003;16(6):598-606.
28. Grignon DJ, Ro JY, Ordonez NG, Ayala AG, Cleary KR. Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study. Hum Pathol. 1988;19(12):1425-1433.
29. Rioux-Leclercq NC, Epstein JI. Unusual morphologic patterns of basal cell hyperplasia of the prostate. Am J Surg Pathol. 2002;26(2):237-243.
30. Hosler GA, Epstein JI. Basal cell hyperplasia: an unusual diagnostic dilemma on prostate needle biopsies. Hum Pathol. 2005;36(5):480-485.
31. Ali TZ, Epstein JI. Basal cell carcinoma of the prostate: a clinicopathologic study of 29 cases. Am J Surg Pathol. 2007;31(5):697-705.
32. Yang XJ, McEntee M, Epstein JI. Distinction of basaloid carcinoma of the prostate from benign basal cell lesions by using immunohistochemistry for bcl-2 and Ki-67. Hum Pathol. 1998;29(12):1447-1450.
33. Bostwick DG, Meiers I. Diagnosis of prostatic carcinoma after therapy. Arch Pathol Lab Med. 2007;131(3):360-371.
34. Cheng L, Cheville JC, Bostwick DG. Diagnosis of prostate cancer in needle biopsies after radiation therapy. Am J Surg Pathol. 1999;23(10):1173-1183.
35. Magi-Galluzzi C, Sanderson H, Epstein JI. Atypia in nonneoplastic prostate glands after radiotherapy for prostate cancer: duration of atypia and relation to type of radiotherapy. Am J Surg Pathol. 2003;27(2):206-212.
36. Sheaff MT, Baithun SI. Effects of radiation on the normal prostate gland. Histopathology. 1997;30(4):341-348.
37. Yang XJ, Laven B, Tretiakova M et al. Detection of a-methylacylcoenzyme A racemase in postradiation prostatic adenocarcinoma. Urology. 2003;62(2):282-286.
38. Milord RA, Kahane H, Epstein JI. Infarct of the prostate gland: experience on needle biopsy specimens. Am J Surg Pathol. 2000;24(10):1378-1384.
39. Gaudin PB, Wheeler TM, Epstein JI. Verumontanum mucosal gland hyperplasia in prostatic needle biopsy specimens: a mimic of low grade prostatic adenocarcinoma. Am J Clin Pathol. 1995;104(6):620-626.
40. Amin MB, Bostwick DG. Pigment in prostatic epithelium and adenocarcinoma: a potential source of diagnostic confusion with seminal vesicular epithelium. Mod Pathol. 1996;9(7):791-795.
41. Gikas PW, Del Buono EA, Epstein JI. Florid hyperplasia of mesonephric remnants involving prostate and periprostatic tissue: possible confusion with adenocarcinoma. Am J Surg Pathol. 1993;17(5):454-460.
42. Bostwick DG, Qian J, Ma J, Muir TE. Mesonephric remnants of the prostate: incidence and histologic spectrum. Mod Pathol. 2003;16(7):630-635.
43. Schowinsky JT, Epstein JI. Distorted rectal tissue on prostate needle biopsy: a mimicker of prostate cancer. Am J Surg Pathol. 2006;30(7):866-870.
44. Rahemtullah A, Oliva E. Nephrogenic adenoma: an update on an innocuous but troublesome entity. Adv Anat Pathol. 2006;13(5):247-255.
45. Tong GX, Melamed J, Mansukhani M et al. PAX2: a reliable marker for nephrogenic adenoma. Mod Pathol. 2006;19(3):356-363.
46. Tong GX, Weeden EM, Hamele-Bena D et al. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis? Am J Surg Pathol. 2008;32(9):1380-1387.
47. Frauenhoffer EE, Ro JY, el-Naggar AK, Ordonez NG, Ayala AG. Clear cell cribriform hyperplasia of the prostate. Immunohistochemical and DNA flow cytometric study. Am J Clin Pathol. 1991;95(4):446-453.
48. Humphrey PA, Kaleem Z, Swanson PE, Vollmer RT. Pseudohyperplastic prostatic adenocarcinoma. Am J Surg Pathol. 1998;22(10):1239-1246.
49. Levi AW, Epstein JI. Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy. Am J Surg Pathol. 2000;24(8):1039-1046.
50. Zhou M, Jiang Z, Epstein JI. Expression and diagnostic utility of amethylacyl- CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Am J Surg Pathol. 2003;27(6):772-778.
51. Stillwell TJ, Engen DE, Farrow GM. The clinical spectrum of granulomatous prostatitis: a report of 200 cases. J Urol. 1987;138(2):320-323.
52. Speights VO, Jr., Brawn PN. Serum prostate specific antigen levels in nonspecific granulomatous prostatitis. Br J Urol. 1996;77(3):408-410.
53. Sebo TJ, Bostwick DG, Farrow GM, Eble JN. prostatic xanthoma: a mimic of prostatic adenocarcinoma. Hum Pathol. 1994;25(4):386-389.
54. Chuang AY, Epstein JI. Xanthoma of the prostate: a mimicker of high-grade prostate adenocarcinoma. Am J Surg Pathol. 2007;31(8):1225-1230.
55. Hameed O, Humphrey PA. p63/AMACR antibody cocktail restaining of prostate needle biopsy tissues after transfer to charged slides: a viable approach in the diagnosis of small atypical foci that are lost on block sectioning. Am J Clin Pathol. 2005;124:708-715.
56. Howarth SM, Griffiths DF, Varma M. Paraganglion of the prostate gland: an uncommon mimic of prostate cancer in needle biopsies. Histopathology. 2005;47(1):114-115.
57. Kawabata K. Paraganglion of the prostate in a needle biopsy: a potential diagnostic pitfall. Arch Pathol Lab Med. 1997;121(5):515-516.
58. Alguacil-Garcia A. Artifactual changes mimicking signet ring cell carcinoma in transurethral prostatectomy specimens. Am J Surg Pathol. 1986; 10(11):795-800.
59. Wang HL, Humphrey PA. Exaggerated signet-ring cell change in stromal nodule of prostate: a pseudoneoplastic proliferation. Am J Surg Pathol. 2002; 26(8):1066-1070.
60. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder: Bladder Consensus Conference Committee. Am J Surg Pathol. 1998;22(12):1435-1448.
61. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004:359. World Health Organization Classification of Tumours; vol 6.
62. McKenney JK, Desai S, Cohen C, Amin MB. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens. Am J Surg Pathol. 2001;25(8):1074-1078.
63. Harnden P, Eardley I, Joyce AD, Southgate J. Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol. 1996;78(6):870-875.
64. Mallofre C, Castillo M, Morente V, Sole M. Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia. Mod Pathol. 2003;16(3):187-191.
65. Kunju LP, Lee CT, Montie J, Shah RB. Utility of cytokeratin 20 and Ki-67 as markers of urothelial dysplasia. Pathol Int. 2005;55(5):248-254.
66. McKenney JK, Amin MB. The role of immunohistochemistry in the diagnosis of urinary bladder neoplasms. Semin Diagn Pathol. 2005;22(1):69-87.
67. Coleman JF, Hansel DE. Utility of diagnostic and prognostic markers in urothelial carcinoma of the bladder. Adv Anat Pathol. 2009;16(2):67-78.
68. Lopez-Beltran A, Luque RJ, Mazzucchelli R, Scarpelli M, Montironi R. Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. J Clin Pathol. 2002;55(9):641-647.
69. Ekelund P, Johansson S. Polypoid cystitis: a catheter associated lesion of the human bladder. Acta Pathol Microbiol Scand A. 1979;87A(3):179-184.
70. Kim SH, Yang DM, Kim NR. Polypoid and papillary cystitis mimicking a large transitional carcinoma in a patient without a history of catheterization: computed tomography and magnetic resonance findings. J Comput Assist Tomogr. 2004;28(4):485-487.
71. Buck EG. Polypoid cystitis mimicking transitional cell carcinoma. J Urol. 1984;131(5):963.
72. Lane Z, Epstein JI. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia. Am J Surg Pathol. 2008;32(5): 758-764.
73. Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma. Oncol Rep. 2006;16(2):329-334.
74. Epstein JI, Amin MB, Reuter VE. Bladder Biopsy Interpretation. Philadelphia: Lippincott Williams & Wilkins; 2004:viii, 263.
75. Baker PM, Young RH. Radiation-induced pseudocarcinomatous proliferations of the urinary bladder: a report of 4 cases. Hum Pathol. 2000;31(6):678-683.
76. Chan TY, Epstein JI. Radiation or chemotherapy cystitis with "pseudocarcinomatous" features. Am J Surg Pathol. 2004;28(7):909-913.
77. Lane Z, Epstein JI. Pseudocarcinomatous epithelial hyperplasia in the bladder unassociated with prior irradiation or chemotherapy. Am J Surg Pathol. 2008;32(1):92-97.
78. Volmar KE, Chan TY, De Marzo AM, Epstein JI. Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma. Am J Surg Pathol. 2003; 27(9):1243-1252.
79. Somigliana E, Vercellini P, Gattei U, Chopin N, Chiodo I, Chapron C. Bladder endometriosis: getting closer and closer to the unifying metastatic hypothesis. Fertil Steril. 2007;87(6):1287-1290.
80. Comiter CV. Endometriosis of the urinary tract. Urol Clin North Am. 2002; 29(3):625-635.
81. Clement PB, Young RH. Endocervicosis of the urinary bladder: a report of six cases of a benign müllerian lesion that may mimic adenocarcinoma. Am J Surg Pathol. 1992;16(6):533-542.
82. Young RH, Clement PB. Mullerianosis of the urinary bladder. Mod Pathol. 1996;9(7):731-737.
83. Bellezza G, Sidoni A, Cavaliere A. Ectopic prostatic tissue in the bladder. Int J Urol. 2005;12(12):1066-1068.